At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor^® sat down with Dr. Aamir Ehsan and Dr. Bridget Herschap from CorePath Laboratories. Dr. Ehsan and Dr. Herschap describe the HemePath Hub, a unique learning opportunity offered by CorePath in which pathologists, residents, and fellows can receive continuing educational training in the cutting-edge technology, business innovation, and specialized skills encompassing all aspects of pathology for hematologic cancers. 

Significant progress has been made in numerous facets of breast cancer care in recent years, including developments in treatment, imaging, pathology, radiation, and surgery. In this interview, Dr. Richard Zelkowitz, a Regional Medical Director of the Breast Program at Hartford HealthCare, highlights the advances that have been made and explains the importance of subspecialties in ensuring that patients with breast cancer receive the most individualized care possible.  

At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Jon Wetzel, Chief Operating Officer (COO), and Leif Honda, Chief Innovation Officer (CIO) of TriMetis, a life sciences technology company, sat down with Oncology Data Advisor to talk about using artificial intelligence (AI) and computer-assisted pathology to revolutionize tissue-based research.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Aamir Ehsan, MD, Medical Director at CorePath Laboratories, spoke with Oncology Data Advisor to delve into the topic of personalized and precise diagnosis of cancer by pathology, a topic that he is passionate about other pathologists and oncologists understanding.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago, by Oncology Data Advisor and ConveyMed. 

In this new podcast, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and Medical Advisory Council member of the National Breast Cancer Foundation, discusses the pathology of breast cancer, prognostic factors for disease outcomes, and the crucial role of breast pathologists in setting the stage for diagnosis and treatment.

Lillie Shockney, RN, BS, MAS, HON-ONN-CG.

In this interview, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and Medical Advisory Council member of the National Breast Cancer Foundation, discusses the pathology of breast cancer, prognostic factors for disease outcomes, and the crucial role of breast pathologists in setting the stage for diagnosis and treatment.